Find Emphysema Patients Before It’s Too Late

COPD is vastly underdiagnosed. One of the biggest challenges for a bronchoscopic lung volume reduction (BLVR) program is identifying qualified patients.

If an HCP doesn’t find them early enough, the disease may progress beyond the point where BLVR is a viable treatment option.¹

Up to 70% of patients are underdiagnosed, meaning 7 out of 10 people suffer without care, and providers never know.²

82% of patients with severe emphysema are only being treated by primary care practitioners or non-procedural pulmonologists.³ These patients are trapped in a primary care loop—never referred, never evaluated for BLVR.

3 out of 4 patients who are referred for BLVR treatment are determined to be ineligible for therapy, resulting in lost time, wasted resources, and false hope for patients.⁴

Over 50% of Patients Drop Off at the Final Step

277 of 545 patients in the EMPROVE clinical trial did not meet BLVR eligibility due to their CT scan results.⁴

As you know, the clinical workup to determine valve candidacy is an intensive process, with the main disqualifer being the last step. Based on feedback from interventional pulmonologists like you, we are helping you start where most patients fail: the CT scan.

Patient SeleCTion Redefined

SeleCT Screening leverages AI to operate silently in the background of your IT and radiology infrastructure to analyze any non-contrast chest CT scans that are performed in your institution for incidental findings of emphysema.

Once a potential patient is identified, their CT images are seamlessly sent to Imbio Inc. (Minneapolis, MN), our medical software partner, for SeleCT QCT analysis. SeleCT reports are then generated for all qualifying patients and are provided to you in a secure online portal for further work-up or outreach, ultimately streamlining patient selection.

SeleCT Screening:

Reduces wasted workups with an advanced algorithm and standardized criteria to prescreen patients based on CT imaging first.
Maximizes efficiency and yield so interventional pulmonologists are only working up potential BLVR candidates.

Automatically assesses and screens any non-contrast chest CT within your hospital’s network for emphysema presence and BLVR therapy eligibility.

Generates a SeleCT™ QCT Report to identify target lobes and fissure integrity scores for potential patients to optimize selection and inform clinical decision making.

Easy-to-read results at your fingertips on a web-based portal. Manage patient care and follow up anytime, anywhere.

Meet patients where they are and connect them with the care they need.

Support your Facility's BLVR Program

SeleCT Screening may help to:

Streamline patient selection for valves

Establish a steady pipeline of treatable patients

Enhance efficiency and scalability of your BLVR program

Optimize resource utilization and support program sustainability

Since implementing SeleCT Screening at our facility, the process of identifying patients for BLVR treatment has been completely transformed…It’s truly remarkable how this advancement has streamlined our workflow and improved patient care.”

– D. Kyle Hogarth, MD, FCCP
Professor of Medicine and Director of Bronchoscopy
Section of Pulmonary and Critical Care Medicine
University of Chicago, Chicago, IL

Dr. Hogarth is a paid consultant of the Olympus Corporation, its subsidiaries and/or its affiliates.

Rethink Your BLVR Selection Process with SeleCT™ Screening

Find Emphysema Patients Before It’s Too Late

Learn more about SeleCT Screening and how it could enhance your BLVR program!

Over 50% of Patients Drop Off at the Final Step

Why Flip the Script?

SeleCT Screening Works While You Work

Patient SeleCTion Redefined

SeleCT Screening:

Support your Facility's BLVR Program

SeleCT Screening may help to:

Hear from a Peer

Since implementing SeleCT Screening at our facility, the process of identifying patients for BLVR treatment has been completely transformed…It’s truly remarkable how this advancement has streamlined our workflow and improved patient care.”